Related references
Note: Only part of the references are listed.Differential Dynamics of Platelet Contact and Spreading
Dooyoung Lee et al.
BIOPHYSICAL JOURNAL (2012)
Alzheimer disease and platelets: how's that relevant
Silvia Catricala et al.
IMMUNITY & AGEING (2012)
Cerebral amyloid angiopathy in the elderly
Anand Viswanathan et al.
ANNALS OF NEUROLOGY (2011)
Epinephrine-mediated protein kinase C and Rap1b activation requires the co-stimulation of Gz-, Gq-, and Gi-coupled receptors
Paolo Lova et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Conformations and Biological Activities of Amyloid Beta Peptide 25-35
L. Millucci et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2010)
Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: Evidence for A beta(25-35)
Yury G. Kaminsky et al.
EXPERIMENTAL NEUROLOGY (2010)
Genetic evidence for a predominant role of PI3Kβ catalytic activity in ITAM- and integrin-mediated signaling in platelets
Ilaria Canobbio et al.
BLOOD (2009)
Expression of amyloid beta peptide in human platelets:: Pivotal role of the phospholipase Cγ2-protein kinase C pathway in platelet activation
Ming-Yi Shen et al.
PHARMACOLOGICAL RESEARCH (2008)
Activation of human platelets by misfolded proteins
Eszter Herczenik et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases
E. E. Gardiner et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Localization of a fibrillar amyloid β-protein binding domain on its precursor
WE Van Nostrand et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Amyloid β interacts with the amyloid precursor protein:: a potential toxic mechanism in Alzheimer's disease
A Lorenzo et al.
NATURE NEUROSCIENCE (2000)
Share Paper
